Chlorothiazide
- Product NDC
- 63323-658
- 11-digit product format
- 633230658
- Labeler code
- 63323
- Product ID
- 63323-658_85e1af90-9f5e-44a1-8bc3-5868be35812b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CHLOROTHIAZIDE SODIUM
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- ANDA090896
- Marketing category
- ANDA
- Marketing start
- 2009-10-21
- Substance
- CHLOROTHIAZIDE SODIUM
- Active strength
- 500 mg/18mL
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Chlorothiazide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CHLOROTHIAZIDE SODIUM | 500 mg/18mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | SN86FG7N2K |
| Rxcui | 484152 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63323-658-20 | Chlorothiazide | 1 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 1 | | 6 |
| 63323-658-20 | Chlorothiazide | 18 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 18 | | 6 |
| 63323-658-94 | Chlorothiazide | 18 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 18 | | 5 |
| 63323-658-94 | Chlorothiazide | 1 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 1 | | 5 |
| 63323-658-27 | Chlorothiazide | 18 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 18 | | 4 |
| 63323-658-27 | Chlorothiazide | 1 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 1 | | 4 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CHLOROTHIAZIDE SODIUM | ACTIVE INGREDIENT | SN86FG7N2K | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| CHLOROTHIAZIDE SODIUM | ACTIVE INGREDIENT | SN86FG7N2K | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| CHLOROTHIAZIDE SODIUM | ACTIVE INGREDIENT | SN86FG7N2K | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| CHLOROTHIAZIDE | ACTIVE MOIETY | 77W477J15H | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| CHLOROTHIAZIDE | ACTIVE MOIETY | 77W477J15H | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| CHLOROTHIAZIDE | ACTIVE MOIETY | 77W477J15H | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 1 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 63323-658 | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20250409_de512e9b-444c-4ae4-8c6b-accd87a02021.zip |
| 63323-658 | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20230613_de250776-461a-4d02-a82e-ffedca1a9cf4.zip |
| 63323-658 | CHLOROTHIAZIDE (CHLOROTHIAZIDE SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20230613_5b5d8a97-1428-4047-8e6c-b778429a26e4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-658-20 | 63323065820 | 1 VIAL in 1 BOX (63323-658-20) / 18 mL in 1 VIAL | 1 vial | 2009-10-21 | 0000-00-00 | No | No | Current |
| 63323-658-27 | 63323065827 | 1 VIAL in 1 BOX (63323-658-27) / 18 mL in 1 VIAL | 1 vial | 2009-10-21 | 0000-00-00 | No | No | Current |
| 63323-658-94 | 63323065894 | 1 VIAL in 1 BOX (63323-658-94) / 18 mL in 1 VIAL | 1 vial | 2009-10-21 | 0000-00-00 | No | No | Current |